A study funded by the U.S. National Institutes of Health detailed the clinical trial of an artificial pancreas system that automatically monitors and regulates blood glucose levels.
The Control-IQ technology is more effective than current techniques at regulating blood glucose levels in persons with type 1 diabetes throughout the day and overnight.
The closed-loop control device tracks blood glucose via a continuous glucose monitor, and automatically dispatches insulin when needed.
Control-IQ is based on a system invented at the University of Virginia, Charlottesville (UVA), with an insulin pump programmed with sophisticated control algorithms based on a mathematical model that uses glucose monitoring data to automatically adjust dosage.
UVA's Boris Kovatchev said, "There is a special safety module dedicated to prevention of hypoglycemia, and there is gradually intensified control overnight to achieve near-normal blood sugar levels every morning."
From U.S. National Institutes of Health
View Full Article
Abstracts Copyright © 2019 SmithBucklin, Washington, DC, USA